 | • レポートコード：GIR-105X12791 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オラパリブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オラパリブの種類別市場規模（錠剤、カプセル）、用途別市場規模（卵巣がん、乳がん、前立腺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オラパリブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Everest Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、カプセル ・用途別分析2016年-2026年：卵巣がん、乳がん、前立腺がん、その他 ・オラパリブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オラパリブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オラパリブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オラパリブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オラパリブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Olaparib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Olaparib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Olaparib market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Olaparib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Capsules
Market segment by Application can be divided into
Ovarian Cancers
Breast Cancers
Prostate Cancers
Other
The key market players for global Olaparib market are listed below:
AstraZeneca
Everest Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Olaparib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Olaparib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablets
1.2.3 Capsules
1.3 Market Analysis by Application
1.3.1 Overview: Global Olaparib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Ovarian Cancers
1.3.3 Breast Cancers
1.3.4 Prostate Cancers
1.3.5 Other
1.4 Global Olaparib Market Size & Forecast
1.4.1 Global Olaparib Sales in Value (2016-2026))
1.4.2 Global Olaparib Sales in Volume (2016-2026)
1.4.3 Global Olaparib Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Olaparib Production Capacity Analysis
1.5.1 Global Olaparib Total Production Capacity (2016-2026)
1.5.2 Global Olaparib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Olaparib Market Drivers
1.6.2 Olaparib Market Restraints
1.6.3 Olaparib Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Olaparib Product and Services
2.1.4 AstraZeneca Olaparib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Everest Pharmaceuticals
2.2.1 Everest Pharmaceuticals Details
2.2.2 Everest Pharmaceuticals Major Business
2.2.3 Everest Pharmaceuticals Olaparib Product and Services
2.2.4 Everest Pharmaceuticals Olaparib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Olaparib Sales by Manufacturer
3.1 Global Olaparib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Olaparib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Olaparib
3.4 Market Concentration Rate
3.4.1 Top 3 Olaparib Manufacturer Market Share
3.4.2 Top 6 Olaparib Manufacturer Market Share
3.5 Global Olaparib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Olaparib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Olaparib Market Size by Region
4.1.1 Global Olaparib Sales in Volume by Region (2016-2026)
4.1.2 Global Olaparib Revenue by Region (2016-2026)
4.2 North America Olaparib Revenue (2016-2026)
4.3 Europe Olaparib Revenue (2016-2026)
4.4 Asia-Pacific Olaparib Revenue (2016-2026)
4.5 South America Olaparib Revenue (2016-2026)
4.6 Middle East and Africa Olaparib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Olaparib Sales in Volume by Type (2016-2026)
5.2 Global Olaparib Revenue by Type (2016-2026)
5.3 Global Olaparib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Olaparib Sales in Volume by Application (2016-2026)
6.2 Global Olaparib Revenue by Application (2016-2026)
6.3 Global Olaparib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Olaparib Sales by Type (2016-2026)
7.2 North America Olaparib Sales by Application (2016-2026)
7.3 North America Olaparib Market Size by Country
7.3.1 North America Olaparib Sales in Volume by Country (2016-2026)
7.3.2 North America Olaparib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Olaparib Sales by Type (2016-2026)
8.2 Europe Olaparib Sales by Application (2016-2026)
8.3 Europe Olaparib Market Size by Country
8.3.1 Europe Olaparib Sales in Volume by Country (2016-2026)
8.3.2 Europe Olaparib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Olaparib Sales by Type (2016-2026)
9.2 Asia-Pacific Olaparib Sales by Application (2016-2026)
9.3 Asia-Pacific Olaparib Market Size by Region
9.3.1 Asia-Pacific Olaparib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Olaparib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Olaparib Sales by Type (2016-2026)
10.2 South America Olaparib Sales by Application (2016-2026)
10.3 South America Olaparib Market Size by Country
10.3.1 South America Olaparib Sales in Volume by Country (2016-2026)
10.3.2 South America Olaparib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Olaparib Sales by Type (2016-2026)
11.2 Middle East & Africa Olaparib Sales by Application (2016-2026)
11.3 Middle East & Africa Olaparib Market Size by Country
11.3.1 Middle East & Africa Olaparib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Olaparib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Olaparib Typical Distributors
12.3 Olaparib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Olaparib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Olaparib Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Olaparib Product and Services
Table 6. AstraZeneca Olaparib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Everest Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Everest Pharmaceuticals Major Business
Table 9. Everest Pharmaceuticals Olaparib Product and Services
Table 10. Everest Pharmaceuticals Olaparib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Olaparib Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global Olaparib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Olaparib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Olaparib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Olaparib Production Site of Key Manufacturer
Table 16. Global Olaparib Sales by Region (2016-2021e) & (K Pcs)
Table 17. Global Olaparib Sales by Region (2021-2026) & (K Pcs)
Table 18. Global Olaparib Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Olaparib Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Olaparib Sales by Type (2016-2021e) & (K Pcs)
Table 21. Global Olaparib Sales by Type (2021-2026) & (K Pcs)
Table 22. Global Olaparib Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Olaparib Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Olaparib Price by Type (2016-2021e) & (USD/Pcs)
Table 25. Global Olaparib Price by Type (2021-2026) & (USD/Pcs)
Table 26. Global Olaparib Sales by Application (2016-2021e) & (K Pcs)
Table 27. Global Olaparib Sales by Application (2021-2026) & (K Pcs)
Table 28. Global Olaparib Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Olaparib Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Olaparib Price by Application (2016-2021e) & (USD/Pcs)
Table 31. Global Olaparib Price by Application (2021-2026) & (USD/Pcs)
Table 32. North America Olaparib Sales by Country (2016-2021e) & (K Pcs)
Table 33. North America Olaparib Sales by Country (2021-2026) & (K Pcs)
Table 34. North America Olaparib Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Olaparib Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Olaparib Sales by Type (2016-2021e) & (K Pcs)
Table 37. North America Olaparib Sales by Type (2021-2026) & (K Pcs)
Table 38. North America Olaparib Sales by Application (2016-2021e) & (K Pcs)
Table 39. North America Olaparib Sales by Application (2021-2026) & (K Pcs)
Table 40. Europe Olaparib Sales by Country (2016-2021e) & (K Pcs)
Table 41. Europe Olaparib Sales by Country (2021-2026) & (K Pcs)
Table 42. Europe Olaparib Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Olaparib Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Olaparib Sales by Type (2016-2021e) & (K Pcs)
Table 45. Europe Olaparib Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Olaparib Sales by Application (2016-2021e) & (K Pcs)
Table 47. Europe Olaparib Sales by Application (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Olaparib Sales by Region (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Olaparib Sales by Region (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Olaparib Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Olaparib Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Olaparib Sales by Type (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Olaparib Sales by Type (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Olaparib Sales by Application (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific Olaparib Sales by Application (2021-2026) & (K Pcs)
Table 56. South America Olaparib Sales by Country (2016-2021e) & (K Pcs)
Table 57. South America Olaparib Sales by Country (2021-2026) & (K Pcs)
Table 58. South America Olaparib Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Olaparib Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Olaparib Sales by Type (2016-2021e) & (K Pcs)
Table 61. South America Olaparib Sales by Type (2021-2026) & (K Pcs)
Table 62. South America Olaparib Sales by Application (2016-2021e) & (K Pcs)
Table 63. South America Olaparib Sales by Application (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Olaparib Sales by Country (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Olaparib Sales by Country (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Olaparib Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Olaparib Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Olaparib Sales by Type (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Olaparib Sales by Type (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Olaparib Sales by Application (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa Olaparib Sales by Application (2021-2026) & (K Pcs)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Olaparib Typical Distributors
Table 75. Olaparib Typical Customers
List of Figures
Figure 1. Olaparib Picture
Figure 2. Global Olaparib Sales Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Capsules
Figure 5. Global Olaparib Sales Market Share by Application in 2020
Figure 6. Ovarian Cancers
Figure 7. Breast Cancers
Figure 8. Prostate Cancers
Figure 9. Other
Figure 10. Global Olaparib Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Olaparib Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Olaparib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Olaparib Sales (2016-2026) & (K Pcs)
Figure 32. Global Olaparib Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Olaparib Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Olaparib Market Drivers
Figure 35. Olaparib Market Restraints
Figure 36. Olaparib Market Trends
Figure 37. Global Olaparib Sales Market Share by Manufacturer in 2020
Figure 38. Global Olaparib Revenue Market Share by Manufacturer in 2020
Figure 39. Olaparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Olaparib Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Olaparib Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Olaparib Sales Market Share by Region (2016-2026)
Figure 43. Global Olaparib Revenue Market Share by Region (2016-2026)
Figure 44. North America Olaparib Revenue (2016-2026) & (USD Million)
Figure 45. Europe Olaparib Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Olaparib Revenue (2016-2026) & (USD Million)
Figure 47. South America Olaparib Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Olaparib Revenue (2016-2026) & (USD Million)
Figure 49. Global Olaparib Sales Market Share by Type (2016-2026)
Figure 50. Global Olaparib Revenue Market Share by Type (2016-2026)
Figure 51. Global Olaparib Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Olaparib Sales Market Share by Application (2016-2026)
Figure 53. Global Olaparib Revenue Market Share by Application (2016-2026)
Figure 54. Global Olaparib Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Olaparib Sales Market Share by Country (2016-2026)
Figure 56. North America Olaparib Revenue Market Share by Country (2016-2026)
Figure 57. North America Olaparib Sales Market Share by Type (2016-2026)
Figure 58. North America Olaparib Sales Market Share by Application (2016-2026)
Figure 59. Europe Olaparib Sales Market Share by Country (2016-2026)
Figure 60. Europe Olaparib Revenue Market Share by Country (2016-2026)
Figure 61. Europe Olaparib Sales Market Share by Type (2016-2026)
Figure 62. Europe Olaparib Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Olaparib Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Olaparib Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Olaparib Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Olaparib Sales Market Share by Application (2016-2026)
Figure 67. South America Olaparib Sales Market Share by Country (2016-2026)
Figure 68. South America Olaparib Revenue Market Share by Country (2016-2026)
Figure 69. South America Olaparib Sales Market Share by Type (2016-2026)
Figure 70. South America Olaparib Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Olaparib Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Olaparib Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Olaparib Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Olaparib Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
非血液学的がんの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. Scope of the Report: This report studies the Non-Hematologic…- 腫瘍栄養の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades. Scope of the Report: This report studies the Oncology Nutrition market status and outlook of Global and major regions, from angles of player…
- エクセターエルロチニブ塩酸塩錠の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Exeter erlotinib hydrochloride tablets are medications indicated for cancer diseases. Scope of the Report: This report focuses on the Exeter Erlotinib hydrochloride tablet in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categ…
- 卵巣がんの遺伝子治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 卵巣がんの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer. Scope of the Report: This report studies the Ovarian Cancer market status and outlook of G…